Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey

被引:58
作者
Kehey, Amy S. [1 ]
Reid, M. Carrington [2 ]
Miller, David H. [3 ]
Fins, Joseph J. [4 ]
Lachs, Mark S. [2 ]
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA
[2] Cornell Univ, Weill Med Coll, Div Geriatr & Gerontol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA
关键词
QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; RECIPIENTS; COMPLICATIONS; DECISIONS; PACEMAKER; VIGNETTES; MANAGEMENT; FREQUENCY; DISEASE;
D O I
10.1016/j.ahj.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Among older adults, implantable cardioverter-defibrillator (ICD) use is increasing. ICD shocks can occur at end of life (EOL) and cause substantial distress, warranting consideration of ICD deactivation discussions. This nationwide physician survey sought to (1) determine if physicians discuss ICD deactivation at the EOL, (2) identify predictors of those discussions, and (3) ascertain physicians' knowledge/attitudes about ICD use. Methods We surveyed 4,876 physicians stratified by specialty (cardiologists, electrophysiologists, general internists, and geriatricians). The mailed survey presented 5 vignettes leg, end-stage chronic obstructive pulmonary disease, advanced dementia) wherein ICD deactivation might be considered and 17 Likert-scaled items. Results Five hundred fifty-eight (12%) physicians returned surveys. Respondents were largely men (77%) and white (69%). Most physicians (56%-83%) said they would initiate deactivation discussions in all 5 vignettes, whereas significantly more (82%-94%) would discuss advance directives and do not resuscitate status. In logistic regression analyses, a history of prior deactivation discussions was an independent predictor of willingness to discuss deactivation (adjusted OR range, 2.8-8.8) in 4 of the 5 vignettes. General internists and geriatricians were less likely than electrophysiologists. to agree that ICD shocks are painful and to distinguish between the ICD's pacing and defibrillator functions. Finally, most physicians believed that informed consent for ICD implantation should include information about deactivation (77%) and endorsed the need for expert guidance in this area (58%). Conclusions Most physicians would discuss ICD deactivation at EOL. The strongest predictor of this was a history of prior discussions. Knowledge about ICDs varies by specialty, and most expressed a desire for more expert guidance about ICD management at EOL. (Am Heart J 2009; 157:702-8.)
引用
收藏
页码:702 / 708
页数:7
相关论文
共 40 条
[1]   Patients' attitudes toward implanted defibrillator shocks [J].
Ahmad, M ;
Bloomstein, L ;
Roelke, M ;
Bernstein, AD ;
Parsonnet, V .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (06) :934-938
[2]   Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients [J].
Alter, P ;
Waldhans, S ;
Plachta, E ;
Moosdorf, R ;
Grimm, W .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09) :926-932
[3]   Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator [J].
Arya, A ;
Haghjoo, M ;
Dehghani, MR ;
Fazelifar, AF ;
Nikoo, MH ;
Bagherzadeh, A ;
Sadr-Ameli, MA .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03) :389-392
[4]  
Ballentine Jennifer M, 2005, Am J Hosp Palliat Care, V22, P14, DOI 10.1177/104990910502200106
[5]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[6]  
Barter C., 1999, SOC RES UPDATE
[7]   End-of-life and other ethical issues related to pacemaker and defibrillator use in the elderly [J].
Basta, LL .
AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY, 2006, 15 (02) :114-117
[8]  
Basta Lofty L, 2002, Am J Geriatr Cardiol, V11, P326, DOI 10.1111/j.1076-7460.2002.01399.x
[9]   The ethics of deactivating implanted cardioverter defibrillators [J].
Berger, JT .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (08) :631-634
[10]  
BOGAN C, 2006, IRAN MED J, V100, P155